Release Date: 23/05/17 12:11 Summary: Company Update- Operating Licenses Secured & New SAS Website Price Sensitive: Yes Download Document 158.9KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%